Pharmabiz

ACG co-founder Jasjit Singh dies at 83 after six decades of contribution to pharma manufacturing

ACG co-founder Jasjit Singh dies at 83 after six decades of contribution to pharma manufacturing: Our Bureau, Mumbai Saturday ...
Pharmabiz

NIU in collaboration with NIIMS launches faculty development programme on NCAHP competency-based curriculum

NIU in collaboration with NIIMS launches faculty development programme on NCAHP competency-based curriculum: Our Bureau, ...
Pharmabiz

AIOCD offers 12.40 lakh chemist network to strengthen govt’s TB Mukt Bharat Abhiyaan

AIOCD offers 12.40 lakh chemist network to strengthen govt’s TB Mukt Bharat Abhiyaan: Peethaambaran Kunnathoor, Chennai ...
Pharmabiz

Osivax, GC Biopharma collaborate to develop a next-generation influenza vaccine candidate combining OVX836 and GC FLU

Osivax, GC Biopharma collaborate to develop a next-generation influenza vaccine candidate combining OVX836 and GC FLU: Lyon, France Saturday, August 29, 2026, 16:00 Hrs [IST] Osiv ...
Pharmabiz

Redx Pharma closes Series A financing of $36 million; changes in board composition

Redx Pharma closes Series A financing of $36 million; changes in board composition: Alderley Park, UK Saturday, August 29, 2026, 17:00 Hrs [IST] Redx Pharma Ltd, a clinical-stage ...
Pharmabiz

Celularity, MuseCell Innovations partner to set up US production of Dezawa MuseCell

Celularity, MuseCell Innovations partner to set up US production of Dezawa MuseCell: Florham Park, New Jersey Saturday, August 29, 2026, 18:00 Hrs [IST] Celularity Inc, a longevit ...
Pharmabiz

UK NICE issues guidance recommending routine NHS funding for Bridge to Life’s VitaSmart Hypothermic Oxygenated Perfusion System

UK NICE issues guidance recommending routine NHS funding for Bridge to Life’s VitaSmart Hypothermic Oxygenated Perfusion System: Duluth, Georgia Saturday, August 29, 2026, 15:00 ...
Pharmabiz

Maharashtra FDA cancels Cipla C&F drug licences in Reactin Plus case for violation of drug norms

Maharashtra FDA cancels Cipla C&F drug licences in Reactin Plus case for violation of drug norms: Our Bureau, Mumbai Saturday, August 29, 2026, 13:15 Hrs [IST] The Maharashtra Foo ...
Pharmabiz

Natera and Angiex partner to assess response to investigational Nuclear-Delivered Antibody-Drug Conjugate using Signatera

Natera and Angiex partner to assess response to investigational Nuclear-Delivered Antibody-Drug Conjugate using Signatera: Austin, Texas Saturday, August 29, 2026, 14:00 Hrs [IST] ...
Pharmabiz

Aurobindo Pharma gets 3 US FDA observations for API facility

Aurobindo Pharma Ltd stated that United States Food and Drug Administration (FDA) inspected Unit-VI, an API manufacturing facility of Apitoria Pharma Private Limited, a wholly owned subsidiary of the ...
Pharmabiz

US FDA accepts Kowa Pharma’s NDA for K-911, an Investigational IOP-lowering eye drop for patients with open-angle glaucoma or ocular hypertension

US FDA accepts Kowa Pharma’s NDA for K-911, an Investigational IOP-lowering eye drop for patients with open-angle glaucoma or ocular hypertension: Montgomery, Alabama Saturday, ...
Pharmabiz

Flexsys narrows 6PPD replacement to two final molecules and enters cooperative R&D pact with US Geological Survey for independent toxicity testing

Flexsys narrows 6PPD replacement to two final molecules and enters cooperative R&D pact with US Geological Survey for independent toxicity testing: Akron, Ohio Saturday, August 29 ...